The research peptide market has a documented quality problem. A 2019 analysis in Analytical and Bioanalytical Chemistry found significant discrepancies between labeled and actual peptide content across multiple suppliers, with purity ranging from under 50% to over 99% for supposedly identical products.
That’s not a minor issue. When a researcher runs an experiment with a 70% pure peptide labeled as 99%, the results are fundamentally unreliable. The 30% contaminant fraction — which may include truncated sequences, deletion mutants, or residual solvents — has its own biological activity that confounds every downstream measurement.
The collapse of Peptide Sciences in March 2026 further highlighted the risks. Researchers who had built protocols around their products suddenly had no way to verify whether historical results were valid. The incident underscored why supplier evaluation isn’t a one-time decision — it’s an ongoing practice.
An Evidence-Based Evaluation Framework
Rather than ranking specific suppliers, this guide provides a framework for evaluating any vendor in the research peptide space. The criteria are based on analytical chemistry standards and supply chain transparency principles that apply regardless of which supplier you’re considering.
1. Independent Third-Party Testing
This is the single most important differentiator. A supplier that only provides in-house COAs is asking you to trust them without verification.
What to look for:
- Named, accredited labs — ISO 17025 accreditation means the lab’s methods have been independently validated. Janoshik Analytical is currently the most recognized independent lab in the peptide space, though university analytical cores and other commercial labs also provide reliable services.
- Full HPLC + mass spectrometry data — not just a purity percentage, but the actual chromatogram and MS spectra
- Verification links — the ability to confirm results independently through the lab’s own portal
Red flag: A supplier that posts images of COAs without lab names, batch numbers, or any way to verify them at the source.
2. Business Transparency
Legitimate suppliers operate as real, traceable businesses:
- Physical address (not just a PO box)
- Registered business entity (LLC, Corp)
- Public WHOIS information on their domain
- Professional contact methods (email, phone)
- Published legal pages (Terms, Privacy, Refund)
If you can’t verify who runs the company, that’s a problem. The research peptide industry has seen multiple cases of anonymous operators disappearing after quality complaints surface.
3. Product Documentation
Beyond COAs, quality suppliers provide:
- Clear storage and handling instructions
- Reconstitution guidelines with appropriate solvents
- Batch/lot tracking
- Expiration or retest dates
This documentation indicates the supplier understands the compounds they’re selling — not just moving inventory.
4. Review Infrastructure
Genuine customer reviews on third-party platforms (Trustpilot, Google Reviews) provide independent accountability. A supplier with zero external reviews or only reviews on their own website lacks the feedback loop that keeps quality honest.
Community feedback on forums and subreddits dedicated to peptide research can also surface quality issues that formal review platforms miss.
How to Apply This Framework
Before placing an order with any supplier, run through this checklist:
- Request a sample COA — can you see full chromatograms and mass spectra?
- Verify the testing lab — does the lab exist independently? Can you contact them to confirm the report?
- Check batch specificity — does the COA match the specific batch you’ll receive, or is it a generic document?
- Search for the business — is the company registered? Can you find a real address and contact information?
- Look for independent reviews — what do other researchers say on platforms the supplier doesn’t control?
- Evaluate pricing — is the price consistent with the cost of proper synthesis, purification, and testing? Significantly below-market pricing usually indicates compromised quality.
No single criterion is definitive. But a supplier that fails multiple items on this list presents a measurable risk to research integrity.
The Broader Problem
The research peptide market is largely unregulated. There is no mandatory testing standard, no required quality framework, and no licensing requirement for suppliers. This means the burden of quality verification falls entirely on the researcher.
That’s unlikely to change soon. Until it does, the evaluation framework above — applied consistently — is the best available tool for protecting research quality and avoiding the kind of supply chain failures that have cost the field credibility.